Dihydroergotamine (DHE) – Then and Now: A Narrative Review

OBJECTIVE: To provide a narrative review of clinical development programs for non‐oral, non‐injectable formulations of dihydroergotamine (DHE) for the treatment of migraine. BACKGROUND: Dihydroergotamine was one of the first “synthetic drugs” developed in the 20th century for treating migraine. It i...

Descripción completa

Detalles Bibliográficos
Autores principales: Silberstein, Stephen D., Shrewsbury, Stephen B., Hoekman, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003832/
https://www.ncbi.nlm.nih.gov/pubmed/31737909
http://dx.doi.org/10.1111/head.13700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003832/
https://www.ncbi.nlm.nih.gov/pubmed/31737909
http://dx.doi.org/10.1111/head.13700

Ejemplares similares